News & Analysis on Clinical Trial Services & Contract Research And Development
Nikon launches a new three-laser entry-level confocal microscope, which builds on the technology of its entry-level system, which meets the growing popularity of confocal imaging in research applications.
SAFC Biosciences has unveiled an analogue of insulin specifically designed for the large-scale manufacturing of recombinant biopharmaceuticals, promising security of supply and product consistency.
In-PharmaTechnologist insulin series
The Tech Group has experienced a quarter of explosive growth as it ramps up production for the launch of Exubera - Pfizer's newly-approved and much-anticipated needle-free insulin.
A new study has suggested a new approach to drug design, which recommends that a loose fit may be the best fit especially when producing drugs for thyroid related conditions.
Vaccine developer Iomai has announced results of a clinical trial showing its new dry patch formulation for travelers' diarrhea can trigger a stronger immune response than its wet patch, promising a vaccine that is easier to administer and tolerate.
Surface modification firm SurModics has acquired Intralytix's polyester-amide (PEA) biodegradable polymers, boosting the company's capacity for specific drug delivery, a capability in high demand by its customers.
Scientists at Atugen, a German-based firm, have successfully used a new RNA interference (RNAi) technology to reduce tumour growth and spread, according to new research published.
European researchers have unlocked more secrets of how the HIV and SARS virus operates, which if exploited could be the starting point for a host of effective antiviral drugs that combat the virus' mechanism of action.
SAFC Biosciences has unveiled an analogue of insulin specifically designed for the large-scale manufacturing of recombitant biopharmaceuticals, promising security of supply and product consistency.